Levothyroxine and insulin requirement in autoimmune polyglandular type 3 syndrome: a real-life study

PURPOSE: To evaluate factors influencing the insulin and levothyroxine requirement in patients with autoimmune polyglandular syndrome type 3 (APS-3) vs. patients with type 1 diabetes mellitus (T1DM) and autoimmune hypothyroidism (AH) alone, respectively. METHODS: Fifty patients with APS-3, 60 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarnotta, V., Pillitteri, G., Gambino, G., Radellini, S., Vigneri, E., Pizzolanti, G., Giordano, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195810/
https://www.ncbi.nlm.nih.gov/pubmed/33099763
http://dx.doi.org/10.1007/s40618-020-01421-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195810/
https://www.ncbi.nlm.nih.gov/pubmed/33099763
http://dx.doi.org/10.1007/s40618-020-01421-3

Ejemplares similares